Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page adds Prostate cancer as a related topic and MedlinePlus Genetics, and updates the revision tag from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed from the page's revision history.SummaryDifference0.1%

- Check20 days agoChange DetectedGlossary feature added to improve understanding on the page and revision metadata updated to v3.4.0, replacing the previous QC label variant. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study protocol document version was updated from v3.3.3 to v3.3.4. This is a minor administrative update to the study documents.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved related topics Prostate cancer and MedlinePlus Genetics from the page's related topics.SummaryDifference0.2%

- Check56 days agoChange DetectedAdded Prostate cancer as a related topic under MedlinePlus Genetics and Wisconsin as a Location, and updated the page revision to v3.3.3. Removed the prior HHS Vulnerability Disclosure and the Wisconsin Locations entry (revision 3.3.2).SummaryDifference0.4%

Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.